Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis

F. K. Holla, T. J. Postma, M. A. Blankenstein, T. J. M. van Mierlo, M. J. Vos, E. M. Sizoo, M. de Groot, B. M. J. Uitdehaag, J. Buter, M. Klein, J. C. Reijneveld, J. J. Heimans

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)
Original languageEnglish
Pages (from-to)525-532
JournalJournal of Neuro-Oncology
Issue number3
Publication statusPublished - Sept 2016


  • Chemotherapy
  • Glioma
  • Prognosis
  • S100B
  • Survival

Cite this